CAPE GIRARDEAU, Missouri—EBO MD is proud to announce that two of the most popular and effective GLP-1 medications—semaglutide and tirzepatide—are now available to members in a convenient, needle-free oral form known as a troche.

Unlike traditional injections, these troches are small, dissolvable tablets placed under the tongue and taken once daily. They deliver the same clinical effectiveness as injectable GLP-1s with a much simpler—and more comfortable—experience for patients.

“This is a major win for accessibility, convenience and cost savings,” said Tony Thompson, co-founder and CEO of EBO MD. “Members now have access to two of the most in-demand medications on the market in a way that fits their lifestyle—no injections, no hassles, and no inflated pharmacy pricing.”

The compounded oral semaglutide and tirzepatide troches are custom-made for each patient and typically ready within 24 to 48 hours. EBO MD’s in-house care team manages the full process, allowing patients to avoid delays, pre-authorizations, or pharmacy confusion.

Key Benefits of Oral GLP-1 Troches from EBO MD:

• Same efficacy as injectables
• No needles required
• Taken once daily
• Compounded for each patient
• Typically ready within 24–48 hours
• Available exclusively to EBO MD members

In addition to their use in weight management, GLP-1 medications have been shown to support blood sugar regulation and reduce appetite—making them an increasingly popular option for patients looking to improve metabolic health.

These medications are available in several dosages and do require refrigeration. Pricing varies by strength and will be discussed during a consultation with an EBO MD provider.

EBO MD members interested in learning more or starting GLP-1 therapy should contact their care team as soon as possible. Initial consultations and ongoing support are included in membership, with no copays or hidden fees.

For more information or to become a member, visit doyouebo.com.